$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

$lsta Overview Financials Valuation SEC Filings Company Website

2015 Q3 Form 10-Q Financial Statement

#000032001715000065 Filed on August 06, 2015

Income Statement

Concept	2015 Q3	2015 Q2	2014 Q2
Revenue	$5.888M	$5.867M	$4.489K
YoY Change	142892.96%	130596.44%	2.98%
Cost Of Revenue	$4.809M	$5.799M	$3.677M
YoY Change	19.85%	57.69%	-13.17%
Gross Profit	$1.080M	$68.17K	-$3.673M
YoY Change	-126.94%	-101.86%	-3052.89%
Gross Profit Margin	18.34%	1.16%	-81819.25%
Selling, General & Admin	$5.147M	$8.736M	$7.446M
YoY Change	-34.8%	17.33%	72.26%
% of Gross Profit	476.69%	12816.13%
Research & Development	$6.316M	$7.601M	$5.796M
YoY Change	-25.43%	31.14%	45.92%
% of Gross Profit	584.9%	11150.18%
Depreciation & Amortization	$640.0K	$650.0K	$550.0K
YoY Change	8.47%	18.18%	96.43%
% of Gross Profit	59.27%	953.54%
Operating Expenses	$16.27M	$31.54M	$16.92M
YoY Change	-20.15%	86.39%	35.04%
Operating Profit	-$10.38M	-$25.67M	-$12.43M
YoY Change	-36.14%	106.5%	52.14%
Interest Expense	$553.0K	$547.3K	$105.9K
YoY Change	201.39%	416.76%	60.84%
% of Operating Profit
Other Income/Expense, Net	-$963.2K	$4.808M	-$291.6K
YoY Change	10.62%	-1748.44%	3594.49%
Pretax Income	-$11.35M	-$20.86M	-$12.72M
YoY Change	-33.76%	63.98%	55.56%
Income Tax	$46.63K	-$3.703M	$47.39K
% Of Pretax Income
Net Earnings	-$11.38K	-$17.13K	-$12.61K
YoY Change	-32.98%	35.87%	47.0%
Net Earnings / Revenue	-0.19%	-0.29%	-280.8%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.062M	-$3.841M	-$3.978M
COMMON SHARES
Basic Shares Outstanding	55.35M shares	40.15M shares	34.01M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q3	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.39M	$39.22M	$33.79M
YoY Change	-10.41%	16.09%	129.84%
Cash & Equivalents	$24.04M	$36.21M	$32.87M
Short-Term Investments	$5.349M	$3.012M	$920.8K
Other Short-Term Assets	$6.700M	$7.000M	$4.500M
YoY Change	3.08%	55.56%	350.0%
Inventory			$2.033M
Prepaid Expenses
Receivables	$2.300M	$1.298M	$2.510M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$38.48M	$47.47M	$40.85M
YoY Change	-7.08%	16.2%	148.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.10M	$16.81M	$15.64M
YoY Change	8.98%	7.5%	43.83%
Goodwill	$25.21M	$25.21M	$14.09M
YoY Change	0.0%	78.89%	26.75%
Intangibles	$37.71M	$37.86M	$49.36M
YoY Change	-20.97%	-23.31%	248.16%
Long-Term Investments
YoY Change
Other Assets	$1.210M	$1.271M	$1.460M
YoY Change	-8.16%	-12.9%	47.33%
Total Long-Term Assets	$81.22M	$81.15M	$92.54M
YoY Change	-9.68%	-12.31%	149.03%
TOTAL ASSETS
Total Short-Term Assets	$38.48M	$47.47M	$40.85M
Total Long-Term Assets	$81.22M	$81.15M	$92.54M
Total Assets	$119.7M	$128.6M	$133.4M
YoY Change	-8.86%	-3.58%	148.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.467M	$2.266M	$5.481M
YoY Change	-43.94%	-58.65%	127.38%
Accrued Expenses	$8.011M	$7.178M	$2.587M
YoY Change	184.22%	177.43%	30.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$900.0K	$200.0K
YoY Change		350.0%	-93.94%
Long-Term Debt Due	$2.751M	$1.361M	$800.0K
YoY Change	175.14%	70.14%	166.67%
Total Short-Term Liabilities	$19.74M	$16.33M	$11.91M
YoY Change	66.52%	37.1%	42.07%
LONG-TERM LIABILITIES
Long-Term Debt	$12.25M	$13.64M	$3.900M
YoY Change	-18.34%	249.71%	1850.0%
Other Long-Term Liabilities	$3.457M	$3.467M	$635.0K
YoY Change	461.28%	446.02%	65.75%
Total Long-Term Liabilities	$15.71M	$17.11M	$635.0K
YoY Change	0.58%	2593.84%	-94.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.74M	$16.33M	$11.91M
Total Long-Term Liabilities	$15.71M	$17.11M	$635.0K
Total Liabilities	$64.71M	$62.67M	$56.10M
YoY Change	-6.6%	11.72%	172.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$338.9M	-$327.6M	-$262.7M
YoY Change	21.21%	24.71%	22.3%
Common Stock	$55.50K	$55.45K	$34.94K
YoY Change	56.39%	58.71%	78.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$705.7K	$705.7K	$705.7K
YoY Change	0.0%	0.0%	6.03%
Treasury Stock Shares
Shareholders Equity	$55.43M	$66.38M	$78.04M
YoY Change
Total Liabilities & Shareholders Equity	$119.7M	$128.6M	$133.4M
YoY Change	-8.86%	-3.58%	148.83%

Cashflow Statement

Concept	2015 Q3	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	-$11.38K	-$17.13K	-$12.61K
YoY Change	-32.98%	35.87%	47.0%
Depreciation, Depletion And Amortization	$640.0K	$650.0K	$550.0K
YoY Change	8.47%	18.18%	96.43%
Cash From Operating Activities	-$8.700M	-$7.590M	-$11.26M
YoY Change	-35.46%	-32.59%	87.98%
INVESTING ACTIVITIES
Capital Expenditures	-$770.0K	-$1.460M	-$1.200M
YoY Change	57.14%	21.67%	445.45%
Acquisitions
YoY Change
Other Investing Activities	-$2.390M	-$3.010M	-$870.0K
YoY Change	-1056.0%	245.98%
Cash From Investing Activities	-$3.150M	-$4.470M	-$2.070M
YoY Change	1212.5%	115.94%	840.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-310.0K	29.14M	4.830M
YoY Change	-102.38%	503.31%	-58.61%
NET CHANGE
Cash From Operating Activities	-8.700M	-7.590M	-11.26M
Cash From Investing Activities	-3.150M	-4.470M	-2.070M
Cash From Financing Activities	-310.0K	29.14M	4.830M
Net Change In Cash	-12.16M	17.08M	-8.500M
YoY Change	1588.89%	-300.94%	-255.68%
FREE CASH FLOW
Cash From Operating Activities	-$8.700M	-$7.590M	-$11.26M
Capital Expenditures	-$770.0K	-$1.460M	-$1.200M
Free Cash Flow	-$7.930M	-$6.130M	-$10.06M
YoY Change	-38.95%	-39.07%	74.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	clbs	Preferred Stock Shares Designated PreferredStockSharesDesignated	825000	shares
CY2015Q2	clbs	Preferred Stock Shares Designated PreferredStockSharesDesignated	825000	shares
CY2014Q4	clbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	1000	USD
CY2015Q2	clbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	0	USD
CY2015Q2	clbs	Aggregate Intrinsic Value Warrantsvested AggregateIntrinsicValueWarrantsvested	0	USD
CY2015Q2	clbs	Aggregate Intrinsic Value Warrantsvestedandexpectedtovest AggregateIntrinsicValueWarrantsvestedandexpectedtovest	0	USD
	clbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
	clbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
CY2014Q2	clbs	Clinical Services Reimbursement ClinicalServicesReimbursement	1100000	USD
	clbs	Clinical Services Reimbursement ClinicalServicesReimbursement	1800000	USD
CY2015Q2	clbs	Clinical Services Reimbursement ClinicalServicesReimbursement	900000	USD
	clbs	Clinical Services Reimbursement ClinicalServicesReimbursement	1400000	USD
CY2014Q4	clbs	Common Stock Warrants Shares CommonStockWarrantsShares	3550956	shares
CY2015Q2	clbs	Common Stock Warrants Shares CommonStockWarrantsShares	3518952	shares
	clbs	Commonstockandcontingentconsiderationissuedinmerger Commonstockandcontingentconsiderationissuedinmerger	35252451	USD
	clbs	Commonstockandcontingentconsiderationissuedinmerger Commonstockandcontingentconsiderationissuedinmerger	0	USD
	clbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-1615234	USD
	clbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	2122987	USD
CY2011Q4	clbs	Percentageof Net Sales PercentageofNetSales	0.10
CY2011Q4	clbs	Percentageoflicensecost Percentageoflicensecost	0.30
	clbs	Provision For Reduction Of Doubtful Accounts ProvisionForReductionOfDoubtfulAccounts	2020	USD
	clbs	Provision For Reduction Of Doubtful Accounts ProvisionForReductionOfDoubtfulAccounts	2641	USD
CY2015Q2	clbs	Sharesvestedandexpectedtovest Sharesvestedandexpectedtovest	3518952	shares
	clbs	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	1373925	USD
CY2015Q2	clbs	Subsidiary Ownership Interest By Parent SubsidiaryOwnershipInterestByParent	0.969
	clbs	Warrants Canceled WarrantsCanceled	32004	shares
	clbs	Warrants Exercised WarrantsExercised	0	shares
	clbs	Warrants Expired WarrantsExpired	0	shares
	clbs	Warrants Granted WarrantsGranted	0	shares
	clbs	Weighted Average Estimated Fair Value Of Restricted Stock WeightedAverageEstimatedFairValueOfRestrictedStock	7.42
	clbs	Weighted Average Estimated Fair Value Of Restricted Stock WeightedAverageEstimatedFairValueOfRestrictedStock	3.16
	clbs	Weighted Average Exercise Price Warrants Canceled WeightedAverageExercisePriceWarrantsCanceled	19.37
CY2015Q2	clbs	Weighted Average Exercise Price Warrants Exercisable WeightedAverageExercisePriceWarrantsExercisable	14.07
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.88
	clbs	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	0.00
	clbs	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	0.00
	clbs	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised	0.00
	us-gaap	Accretion Expense AccretionExpense	0	USD
	us-gaap	Accretion Expense AccretionExpense	33054	USD
CY2014Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	18260000	USD
CY2015Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	13460000	USD
CY2014Q4	clbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	14.12
CY2015Q2	clbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	14.07
CY2015Q2	clbs	Weighted Average Exercise Price Warrantsvestedexpectedtovest WeightedAverageExercisePriceWarrantsvestedexpectedtovest	14.07
CY2014	clbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P2Y1M13D
	clbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P1Y7M24D
	clbs	Weighted Average Remaining Contractual Termwarrantsvested WeightedAverageRemainingContractualTermwarrantsvested	P1Y7M21D
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000320017
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55349712	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Caladrius Biosciences, Inc.
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5661173	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2266337	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3111274	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1297538	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4322901	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7178022	USD
CY2014Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4322900	USD
CY2015Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	7178000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	495400	USD
CY2015Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	735900	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1329	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1866	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	350428903	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	394589826	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1759700	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5653500	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4416300	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8132100	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	385362	USD
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	382721	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151300	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	302600	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151300	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	302600	USD
CY2014Q4	us-gaap	Assets Assets	126275392	USD
CY2015Q2	us-gaap	Assets Assets	128624746	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	18260000	USD
CY2014Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	12800000	USD
CY2015Q2	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	13500000	USD
CY2015Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	13460000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	11900000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	36281544	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	47474589	USD
CY2015Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	28320500	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	7080000	USD
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3011700	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	22358200	USD
CY2015Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	28320500	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	0	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	1800	USD
CY2014Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	7080100	USD
CY2015Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	3011700	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis	28322400	USD
CY2015Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	28322400	USD
CY2015Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	0	USD
CY2014Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	33500000	USD
CY2014Q2	us-gaap	Business Combination Acquired Receivables Fair Value BusinessCombinationAcquiredReceivablesFairValue	45000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	400000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4800000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	90000000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	51000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	201000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	19000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	333000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent	13901000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	34290000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	2014000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	19400000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1041000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	33491000	USD
CY2014Q4	us-gaap	Cash Cash	15279400	USD
CY2015Q2	us-gaap	Cash Cash	25310700	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	50894	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46133759	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32865071	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19174061	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36211324	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-13268688	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	17037263	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36783857	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55453014	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5329593	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36783857	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55453014	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	36784	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	55453	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12604020	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26286076	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17124394	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36312619	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-164474	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-312502	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-31757	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-76349	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12768494	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-26598578	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-17156151	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-36388968	USD
CY2014Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0.01	shares
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	18176190	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4334120	USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4643033	USD
CY2015Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	-3700000	USD
CY2015Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	14519460	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	1300	USD
CY2015Q2	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	3700	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	987698	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1254305	USD
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.40
CY2015Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0.01	shares
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	3677355	USD
	us-gaap	Cost Of Revenue CostOfRevenue	7503370	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	5798796	USD
	us-gaap	Cost Of Revenue CostOfRevenue	9167408	USD
CY2014Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	0	USD
CY2015Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	600000	USD
	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	10000000	USD
CY2014Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	2566989	USD
CY2015Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	2973487	USD
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.88
CY2014Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	2807200	USD
CY2015Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3459100	USD
CY2014Q2	us-gaap	Equity Issued In Business Combination Fair Value Disclosure EquityIssuedInBusinessCombinationFairValueDisclosure	21600000	USD
CY2014Q4	us-gaap	Fair Value Estimate Not Practicable Investments FairValueEstimateNotPracticableInvestments	22359500	USD
CY2015Q2	us-gaap	Fair Value Estimate Not Practicable Investments FairValueEstimateNotPracticableInvestments	28322400	USD
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-4800000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2498600	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2801200	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	35134400	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	302600	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	605200	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	605200	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	605200	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	605200	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50059000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	40659000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47560400	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	37857800	USD
CY2014Q4	us-gaap	Goodwill Goodwill	25209336	USD
CY2015Q2	us-gaap	Goodwill Goodwill	25209336	USD
CY2014Q2	us-gaap	Goodwill Goodwill	14092000	USD
CY2015Q2	us-gaap	Goodwill Gross GoodwillGross	25200000	USD
CY2014Q2	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2015Q2	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	9400000	USD
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	9400000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-164474	USD
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-312502	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-31757	USD
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-76349	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12722105	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26504780	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20861380	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40046235	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47387	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	94796	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3703363	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3656730	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	602132	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1816376	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-94796	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	3656730	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1013946	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	308912	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	762788	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	406498	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	106909	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8005	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	944297	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-368620	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47560406	USD
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	37857801	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	105906	USD
	us-gaap	Interest Expense InterestExpense	200062	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	547275	USD
	us-gaap	Interest Expense InterestExpense	1098239	USD
	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	600000	USD
	us-gaap	Interest Paid InterestPaid	196200	USD
	us-gaap	Interest Paid InterestPaid	744811	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	5653451	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	8132106	USD
CY2014Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	500000	USD
CY2015Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	800000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	68201603	USD
CY2015Q2	us-gaap	Liabilities Liabilities	62671405	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	126275392	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	128624746	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16244582	USD
CY2015Q2	us-gaap	Long Term Debt LongTermDebt	18800000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1109612	USD
CY2015Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1361148	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6200000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6700000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5300000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	600000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13890388	USD
CY2015Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13638852	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	16331236	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	825897	USD
CY2015Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	1254609	USD
CY2014Q4	us-gaap	Marketable Securities MarketableSecurities	7080053	USD
CY2015Q2	us-gaap	Marketable Securities MarketableSecurities	3011693	USD
CY2014Q4	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	22359500	USD
CY2015Q2	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	28322400	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-441047	USD
CY2015Q2	us-gaap	Minority Interest MinorityInterest	-428468	USD
CY2015Q2	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.031
CY2015Q2	us-gaap	Mortgage Loans On Real Estate Carrying Amount Of Mortgages MortgageLoansOnRealEstateCarryingAmountOfMortgages	3100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12545753	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36631046	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3308201	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2233236	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22506240	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21827019	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12605018	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26287074	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17126260	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36313156	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-291643	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-575350	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4807570	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3710579	USD
CY2014Q4	us-gaap	Notes Payable NotesPayable	1600000	USD
CY2015Q2	us-gaap	Notes Payable NotesPayable	2100000	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	816776	USD
CY2015Q2	us-gaap	Notes Payable Current NotesPayableCurrent	882696	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	16919394	USD
	us-gaap	Operating Expenses OperatingExpenses	34473937	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	31535913	USD
	us-gaap	Operating Expenses OperatingExpenses	52796056	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-12430462	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25929430	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-25668950	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-43756814	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	7895900	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1949600	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1034800	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1863800	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2062000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	985700	USD
CY2014Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	177200000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1020300	USD
CY2015Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	2383000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1263375	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1271381	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	998	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	537	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	998	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	998	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1866	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	537	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	998	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	998	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1866	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	537	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	804546	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3467248	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-185737	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-375288	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5354845	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4808818	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	100000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	919829	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3013157	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2439266	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1802607	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4349167	USD
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3980547	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	11700000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	10149439	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	36136414	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1340981	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1089611	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	7049000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	230183	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1373925	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	-12769492	USD
	us-gaap	Profit Loss ProfitLoss	-26599576	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	-17158017	USD
	us-gaap	Profit Loss ProfitLoss	-36389505	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15960731	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16811639	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	443325	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	594979	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	105450	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5796022	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10554535	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7600744	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14404376	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-291246538	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-327559694	USD
CY2014Q2	us-gaap	Revenues Revenues	4488932	USD
	us-gaap	Revenues Revenues	8544507	USD
CY2015Q2	us-gaap	Revenues Revenues	5866963	USD
	us-gaap	Revenues Revenues	9039242	USD
CY2014Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	20000000	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7446017	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16416032	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8736373	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19824272	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3516452	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28600	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	456709	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1276053	shares
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	24462451	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10149438	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	36136414	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	3389700	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	4029500	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5653451	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8132106	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	58514836	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	66381809	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	62026435	USD
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	77297305	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	58073789	USD
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	65953341	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	705742	USD
CY2015Q2	us-gaap	Treasury Stock Value TreasuryStockValue	705742	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	23175	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2014Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	31739417	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29940128	shares
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	44574796	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41104127	shares

Files In Submission

Name	View Source	Status
0000320017-15-000065-index-headers.html	Edgar Link	pending
0000320017-15-000065-index.html	Edgar Link	pending
0000320017-15-000065.txt	Edgar Link	pending
0000320017-15-000065-xbrl.zip	Edgar Link	pending
clbs-10qx20150630.htm	Edgar Link	pending
clbs-20150630.xml	Edgar Link	completed
clbs-20150630.xsd	Edgar Link	pending
clbs-20150630_cal.xml	Edgar Link	unprocessable
clbs-20150630_def.xml	Edgar Link	unprocessable
clbs-20150630_lab.xml	Edgar Link	unprocessable
clbs-20150630_pre.xml	Edgar Link	unprocessable
clbs-ex311_20150630xq2.htm	Edgar Link	pending
clbs-ex312_20150630xq2.htm	Edgar Link	pending
clbs-ex321_20150630xq2.htm	Edgar Link	pending
clbs-ex322_20150630xq2.htm	Edgar Link	pending
exhibit101lsaamendment.htm	Edgar Link	pending
exhibit31amendarticles.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

2015 Q3 Form 10-Q Financial Statement

#000032001715000065 Filed on August 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA LISATA THERAPEUTICS, INC. Stock $lsta

2015 Q3 Form 10-Q Financial Statement

#000032001715000065 Filed on August 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta